title: [Feared complications in patients treated for inflammatory disease in the era of biotherapeutic products].
authors.affiliation: Service de Médecine interne et Pédiatrie générale, Centre de compétence des arthrites juvéniles idiopathiques et maladies auto-inflammatoires, Hôpital des Enfants, 330 avenue de Grande Bretagne, 31059 Toulouse cedex 9, France. Electronic address: pajot.c@chu-toulouse.fr.
authors.forename: C
authors.initials: C
authors.lastname: Audouin-Pajot
authors.affiliation: Service de Médecine interne et Pédiatrie générale, Centre de compétence des arthrites juvéniles idiopathiques et maladies auto-inflammatoires, Hôpital des Enfants, 330 avenue de Grande Bretagne, 31059 Toulouse cedex 9, France.
authors.forename: C
authors.initials: C
authors.lastname: Bréhin
mesh_terms: D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D007249:Inflammation / Q000188:drug therapy*; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha; D008727:Methotrexate